Ardent Health Partners, Inc. (ARDT) Stock Forecast & Price Target

Compare

72 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ARDT Analyst Ratings

Strong Buy

7 Buy

1 Hold

0 Sell

Based on 8 analysts giving stock ratings to

Ardent

Health Partners, Inc.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ARDT Stock 12 Month Forecast

Average Price Target

$21.17

▲(57.75%Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Ardent Health Partners, Inc. in the last 3 months. The average price target is $21.17 with a high forecast of $24.00 and a low forecast of $18.00. The average price target represents a 57.75% change from the last price of $13.42.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","18":"$18","25":"$25","14.5":"$14.5","21.5":"$21.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$21.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$18.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,14.5,18,21.5,25],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.41,15.147692307692308,15.885384615384616,16.623076923076923,17.36076923076923,18.09846153846154,18.836153846153845,19.573846153846155,20.31153846153846,21.049230769230768,21.786923076923078,22.524615384615384,23.262307692307694,{"y":24,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.41,14.93,15.450000000000001,15.97,16.490000000000002,17.01,17.53,18.05,18.57,19.090000000000003,19.61,20.130000000000003,20.650000000000002,{"y":21.17,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.41,14.686153846153847,14.962307692307693,15.23846153846154,15.514615384615384,15.79076923076923,16.066923076923075,16.34307692307692,16.619230769230768,16.895384615384614,17.17153846153846,17.447692307692307,17.723846153846154,{"y":18,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.3,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.97,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.97,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.83,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.91,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.7,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.35,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.08,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.66,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.97,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.59,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.41,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$24.00

Average Price Target$21.17

Lowest Price Target$18.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$15

Buy

11.77%

Upside

Reiterated

06/10/25

Ardent Health Partners, Inc. shows strong financial performance, with improvements in profitability and cash flow. The earnings call provided positive insights, indicating effective growth strategies and operational improvements. However, mixed technical indicators and the absence of a dividend yield moderate the overall score. The company's valuation suggests potential for appreciation, supported by a low P/E ratio.

Whit MayoLeerink Partners

Leerink Partners

$24

Buy

78.84%

Upside

Reiterated

06/24/25

Buy Rating for Ardent Health Partners, Inc. Amid Strong Sector Trends and Discounted Valuation

Matthew Gillmor CFAKeyBanc

KeyBanc

$24

Buy

78.84%

Upside

Reiterated

06/20/25

Ardent Health Partners, Inc. (ARDT) Gets a Buy from KeyBanc

Craig HettenbachMorgan Stanley

Morgan Stanley

$22

Buy

63.93%

Upside

Reiterated

06/17/25

Ardent Health Partners, Inc.: Strategic Growth and Stable Outlook Justify Buy Rating

Joanna GajukBank of America Securities

Bank of America Securities

―

Hold

―

Reiterated

05/16/25

Ardent Health Partners, Inc. (ARDT) Receives a Hold from Bank of America Securities

Ben HendrixRBC Capital

RBC Capital

$21

Buy

56.48%

Upside

Reiterated

05/14/25

RBC Capital Reaffirms Their Buy Rating on Ardent Health Partners, Inc. (ARDT)

Jason CassorlaGuggenheim

Guggenheim

$16→$18

Buy

34.13%

Upside

Reiterated

05/09/25

Ardent Health price target raised to $18 from $16 at GuggenheimArdent Health price target raised to $18 from $16 at Guggenheim

David S MacdonaldTruist Financial

Truist Financial

―

Buy

―

Reiterated

05/07/25

Analysts Offer Insights on Healthcare Companies: Curis (NASDAQ: CRIS), Ardent Health Partners, Inc. (NYSE: ARDT) and Agilon Health (NYSE: AGL)

Ann HynesMizuho Securities

Mizuho Securities

$19→$18

Buy

34.13%

Upside

Reiterated

04/09/25

Ardent Health price target lowered to $18 from $19 at MizuhoArdent Health price target lowered to $18 from $19 at Mizuho

Benjamin RossiJ.P. Morgan

J.P. Morgan

$20→$18

Hold

34.13%

Upside

Reiterated

03/12/25

Ardent Health Partners, Inc. (ARDT) Receives a Hold from J.P. Morgan

Timothy GreavesLoop Capital Markets

Loop Capital Markets

$21

Buy

56.48%

Upside

Reiterated

01/08/25

Loop Capital Markets Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$15

Buy

11.77%

Upside

Reiterated

06/10/25

Whit MayoLeerink Partners

Leerink Partners

$24

Buy

78.84%

Upside

Reiterated

06/24/25

Buy Rating for Ardent Health Partners, Inc. Amid Strong Sector Trends and Discounted Valuation

Matthew Gillmor CFAKeyBanc

KeyBanc

$24

Buy

78.84%

Upside

Reiterated

06/20/25

Ardent Health Partners, Inc. (ARDT) Gets a Buy from KeyBanc

Craig HettenbachMorgan Stanley

Morgan Stanley

$22

Buy

63.93%

Upside

Reiterated

06/17/25

Ardent Health Partners, Inc.: Strategic Growth and Stable Outlook Justify Buy Rating

Joanna GajukBank of America Securities

Bank of America Securities

―

Hold

―

Reiterated

05/16/25

Ardent Health Partners, Inc. (ARDT) Receives a Hold from Bank of America Securities

Ben HendrixRBC Capital

RBC Capital

$21

Buy

56.48%

Upside

Reiterated

05/14/25

RBC Capital Reaffirms Their Buy Rating on Ardent Health Partners, Inc. (ARDT)

Jason CassorlaGuggenheim

Guggenheim

$16→$18

Buy

34.13%

Upside

Reiterated

05/09/25

Ardent Health price target raised to $18 from $16 at GuggenheimArdent Health price target raised to $18 from $16 at Guggenheim

David S MacdonaldTruist Financial

Truist Financial

―

Buy

―

Reiterated

05/07/25

Analysts Offer Insights on Healthcare Companies: Curis (NASDAQ: CRIS), Ardent Health Partners, Inc. (NYSE: ARDT) and Agilon Health (NYSE: AGL)

Ann HynesMizuho Securities

Mizuho Securities

$19→$18

Buy

34.13%

Upside

Reiterated

04/09/25

Ardent Health price target lowered to $18 from $19 at MizuhoArdent Health price target lowered to $18 from $19 at Mizuho

Benjamin RossiJ.P. Morgan

J.P. Morgan

$20→$18

Hold

34.13%

Upside

Reiterated

03/12/25

Ardent Health Partners, Inc. (ARDT) Receives a Hold from J.P. Morgan

Timothy GreavesLoop Capital Markets

Loop Capital Markets

$21

Buy

56.48%

Upside

Reiterated

01/08/25

Loop Capital Markets Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ardent Health Partners, Inc.

1 Month

xxx

Success Rate

5/8 ratings generated profit

Average Return

-2.23%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of -2.23% per trade.

3 Months

xxx

Success Rate

3/9 ratings generated profit

Average Return

-6.18%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -6.18% per trade.

1 Year

Craig HettenbachMorgan Stanley

Success Rate

1/8 ratings generated profit

Average Return

-14.47%

reiterated a buy rating 19 days ago

Copying Craig Hettenbach's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -14.47% per trade.

2 Years

xxx

Success Rate

1/8 ratings generated profit

Average Return

-14.47%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 12.50% of your transactions generating a profit, with an average return of -14.47% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARDT Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ARDT has received 13 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ARDT average Analyst price target in the past 3 months is 21.17.

Each month's total comprises the sum of three months' worth of ratings.

ARDT Financial Forecast

ARDT Earnings Forecast

Next quarter’s earnings estimate for ARDT is $0.58 with a range of $0.54 to $0.64. The previous quarter’s EPS was $0.29. ARDT beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year ARDT has Outperformed its overall industry.

ARDT Sales Forecast

Next quarter’s sales forecast for ARDT is $1.60B with a range of $1.56B to $1.63B. The previous quarter’s sales results were $1.50B. ARDT beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year ARDT has Outperformed its overall industry.

ARDT Stock Forecast FAQ

What is ARDT’s average 12-month price target, according to analysts?

Based on analyst ratings, Ardent Health Partners, Inc.’s 12-month average price target is 21.17.

What is ARDT’s upside potential, based on the analysts’ average price target?

Ardent Health Partners, Inc. has 57.75% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ARDT a Buy, Sell or Hold?

Ardent Health Partners, Inc. has a consensus rating of Strong Buy which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.

What is Ardent Health Partners, Inc.’s price target?

The average price target for Ardent Health Partners, Inc. is 21.17. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $24.00 ,the lowest forecast is $18.00. The average price target represents 57.75% Increase from the current price of $13.42.

What do analysts say about Ardent Health Partners, Inc.?

Ardent Health Partners, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of ARDT?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Ardent Health Partners, Inc. (ARDT) Stock Forecast & Price Target

ARDT Analyst Ratings

ARDT Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Ardent Health Partners, Inc.

ARDT Analyst Recommendation Trends

ARDT Financial Forecast

ARDT Earnings Forecast

ARDT Sales Forecast

ARDT Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts